Human brain infarcts: Gd-DTPA-enhanced MR imaging

During Food and Drug Administration phase II and III clinical trials for gadolinium DTPA, the paramagnetic agent was used to study 11 patients with 20 subacute and chronic cerebral infarcts. Five patients had numerous periventricular and deep white-matter lesions, probably due to chronic ischemic disease. Magnetic resonance (MR) imaging was performed 4-30 days after the ictus, preceded by computed tomography (CT) in all but one case. In most cases, the nonenhanced spin-echo (SE) images, obtained at 500-msec repetition times and 30-msec echo times, failed to demonstrate the infarct, and in general the gadolinium-enhanced SE 500/30 images matched the contrast material-enhanced CT scans in pattern. Periventricular lesions and small, deep, white-matter infarcts that were chronic and asymptomatic were not enhanced by gadolinium MR. However, three small, symptomatic capsular and brain-stem infarcts showed definite enhancement. Usually the enhancement was visible at 3 minutes, increasing to a peak at 30 minutes. At 55 minutes, the enhancement increased in the medium-aged infarcts (8-14 days), while it decreased in the late infarcts (15-30 days). The T2 relaxation time-weighted pulse sequences were most sensitive for demonstrating all infarcts, but without the aid of a contrast agent, they were frequently poor in specificity.     

Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging

Liposomal gadolinium diethylenetriaminepentaacetic acid (DTPA) encapsulated within 70- and 400-nm vesicles was tested as a contrast agent for magnetic resonance (MR) imaging of the liver in rats with hepatic metastases. Liposomal Gd-DTPA caused significant improvement in contrast between liver and tumor (P less than .005) on T1-weighted MR images. Smaller 70-nm liposomal Gd-DTPA vesicles caused greater contrast enhancement, reflecting the larger surface-area-to-volume ratio of the smaller vesicles. Liposomal Gd-DTPA-enhanced images permitted significant improvement in metastasis detection by five blinded radiologists (P less than .005). By comparison, free Gd-DTPA without liposomes caused a statistically significant reduction in contrast between tumor and liver and reduced lesion detection (P less than .01). Liposomal Gd-DTPA also resulted in sustained vascular enhancement for 1 hour after administration. The results suggest that paramagnetic liposomes may become a useful MR imaging contrast agent.     

Gd-DTPA-enhanced MR imaging of spinal tumors

Forty-eight Gd-DTPA-enhanced MR examinations of the spine were performed in 40 patients referred for MR because of clinically suspected spinal tumor or for further evaluation of an expanded cord. The study group consisted of 32 patients with spinal tumors (seven ependymomas; seven astrocytomas; four hemangioblastomas; two arteriovenous malformations; two unidentified intramedullary neoplasms; four meningiomas; and single cases of metastatic breast carcinoma, cavernous hemangioma with associated hematomyelia, neurinoma, angiolipoma, drop metastasis from medulloblastoma, and epidermoid with diastematomyelia). In the remaining eight patients, other diagnoses were established: thoracic disk herniation (two patients), lumbosacral meningocele (one), syringomyelia secondary to arachnoiditis (four), and expanded cord secondary to gliotic tissue (one). All but two diagnoses were proved histologically by biopsy, surgery, or autopsy; in the two patients with arteriovenous malformations, the definitive diagnosis was made by spinal angiography. Contrast enhancement occurred in 30 of the 32 spinal tumors, and Gd-DTPA-enhanced T1-weighted images proved helpful in defining and outlining intra- and extramedullary spinal neoplasms. All ependymomas and astrocytomas (including low-grade astrocytomas) enhanced. In meningiomas, an immediate and uniform contrast uptake was demonstrated. Additional advantages of Gd-DTPA MR include the differentiation of solid tumor components vs syrinx or cyst or pseudotumoral areas of cord expansion, and the differentiation of residual or recurrent tumor from scar tissue in postoperative patients. Our results suggest that IV-injected Gd-DTPA improves MR sensitivity and specificity in the evaluation of spinal lesions.     

Gd-DTPA-enhanced MR imaging of pituitary adenomas

Eleven previously nonoperated patients with suspected pituitary microadenomas were scanned on a 1.5-T GE system before and after administration of IV gadolinium-DTPA (0.1 mmol/kg). Six patients had Cushing disease, four had hyperprolactinemia, and one had acromegaly. Surgical confirmation was available in all cases, and these findings were correlated with results of CT and venous sampling, when available. The normal pituitary gland, infundibulum, and cavernous sinuses enhance immediately after the administration of gadolinium-DTPA, allowing contrast between the enhancing normal glandular tissue and low-intensity microadenomas. Contrast-enhanced MR detected a lesion not seen on the unenhanced images in two patients with Cushing disease and in one patient with hyperprolactinemia. Tumor delineation was improved with gadolinium administration in two additional cases. In six patients, administration of gadolinium did not significantly alter the precontrast interpretation. Adenomas were found at surgery in all 11 patients. The tumor was correctly localized on MR in four of the six patients with Cushing disease, resulting in an accuracy of 66.7%. In another patient, although a focal lesion was detected on MR, location of the adenoma at surgery was discrepant with the MR findings and was therefore considered a false-positive study. In the single false-negative examination, both pre- and postcontrast MR failed to detect a surgically confirmed microadenoma suspected on both contrast-enhanced CT and venous sampling. Correct localization of the adenoma was achieved in all of the five non-Cushing patients, yielding an accuracy of 100%. Immediate T1-weighted coronal scans were most useful in detecting intrasellar disease. Delayed scans obtained 30 min after injection did not improve the differentiation of pituitary gland from microadenoma.(ABSTRACT TRUNCATED AT 250 WORDS)     

Gd-DTPA-enhanced MR imaging of cryptococcal meningoencephalitis

Summary This report describes magnetic resonance (MR) imaging of biopsy-proved cryptococcal central nervous system (CNS) infection in a 31-year-old HIV negative man. Initial MR imaging revealed multi-focal Gd-DTPA enhancement and showed more lesions than contrast enhanced CT. The lesions regressed after antifungal therapy. MR imaging aids in diagnosis as well as helps to monitor the response to the pharmacological therapy of cryptococcal meningoencephalitis and possibly provides valuable insights into the pathophysiology of this condition.     

Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.

In a study comprising 40 patients with pituitary macroadenomas, MR imaging was performed before and after administration of Gd-DTPA. Before contrast administration T1- and T2-weighted images were obtained, and after the injection, frontal and/or sagittal T1-weighted images. Tumour extension and delineation, relationship to adjacent structures, and signal intensity patterns were evaluated. Compared with pre-contrast T1-weighted images only, post-contrast images provided considerable additional information, but not infrequently this information could also be extracted from pre-contrast T2-weighted images. Post-contrast images were superior regarding the tumour relationship to the cavernous sinus and to the normal pituitary tissue. T2-weighted images were helpful in the diagnosis of degenerative changes, in particular intratumoural haemorrhage. A positive correlation was found between the T2 value (from dual echo sequences) and the degree of enhancement in areas with an appearance of solid tumour tissue, and the enhancement was significantly lower in GH-secreting tumours than in non-secreting ones. It is concluded that the use of Gd-DTPA is often justified in pituitary macroadenomas, particularly in pre-operative evaluation.     

Multiple cerebral metastases: detectability with Gd-DTPA-enhanced MR imaging

Sixteen patients with suspected cerebral metastases were studied with magnetic resonance (MR) imaging before and after the intravenous administration of 0.1 mmol/kg of gadolinium diethylenetriaminepenta-acetic acid. The images were interpreted blindly by two neuroradiologists; all clinical, radiologic (computed tomographic and MR imaging), and pathologic data were reviewed to arrive at a final "best diagnosis," which was then compared with the prior blinded interpretations. Of seven patients found to have multiple metastases, six (86%) had at least one tumor nodule depicted by postinfusion MR imaging that was missed by one or both observers on review of preinfusion images alone. Lesions missed on preinfusion studies were usually small nodules hidden by or not detected next to regions of high-signal edema thought to be related to the adjacent tumor nodule. The authors believe that contrast enhancement improves detection of metastatic foci with MR imaging and that the findings indicate broader implications for the detection of multiple lesions from other causes.     

Tears of the anulus fibrosus: assessment with Gd-DTPA-enhanced MR imaging

T2-weighted images have been shown to be capable of defining anular tears in vitro as increased signal intensity within the normal low-signal-intensity anulus fibrosus. Since growth of granulation tissue into anular tears has been described as part of the healing process, it seemed likely that gadolinium-DTPA should enhance anular tears as it does scar tissue in other parts of the spine. We retrospectively reviewed spinal MR images from 30 previously unoperated patients and correlated areas of increased signal intensity within the anulus on T2-weighted images with areas of enhancement on T1-weighted images, and to a limited extent, with surgical findings. Eighteen separate areas of anular enhancement were found in 12 patients (six cervical, 12 lumbar). Only five of these enhancing areas showed increased signal intensity on T2-weighted images, four of a type II tear pattern and one of a type III tear pattern. Contrast enhancement within the anulus was in a pattern of type II tear in 14 and type III in four. Histology from an enhancing type II anulus demonstrated vascularized granulation tissue within the avascular anulus, without focal herniation. Anular tears may be imaged in vivo not only with T2-weighted images but also with gadolinium-DTPA-enhanced T1-weighted images by virtue of their vascularized granulation tissue.     

Tears of the anulus fibrosus: assessment with Gd-DTPA-enhanced MR imaging

T2-weighted images have been shown to be capable of defining anular tears in vitro as increased signal intensity within the normal low-signal-intensity anulus fibrosus. Since growth of granulation tissue into anular tears has been described as part of the healing process, it seemed likely that gadolinium-DTPA should enhance anular tears as it does scar tissue in other parts of the spine. We retrospectively reviewed spinal MR images from 30 previously unoperated patients and correlated areas of increased signal intensity within the anulus on T2-weighted images with areas of enhancement on T1-weighted images, and to a limited extent, with surgical findings. Eighteen separate areas of anular enhancement were found in 12 patients (six cervical, 12 lumbar). Only five of these enhancing areas showed increased signal intensity on T2-weighted images, four of a type II tear pattern and one of a type III tear pattern. Contrast enhancement within the anulus was in a pattern of type II tear in 14 and type III in four. Histology from an enhancing type II anulus demonstrated vascularized granulation tissue within the avascular anulus, without focal herniation. Anular tears may be imaged in vivo not only with T2-weighted images but also with gadolinium-DTPA-enhanced T1-weighted images by virtue of their vascularized granulation tissue.     

Gd-DTPA-enhanced MR imaging of the normal facial nerve]

We performed a prospective imaging study of the normal facial nerve within the temporal bone before and after injection of Gd-DTPA. The study included 29 patients using a 1.5T superconducting unit and 40 nerves (right: 21; left: 19) were available for analysis. There was no enhancement of the facial nerve within the internal auditory canal in the entire series. However, the enhancement at the labyrinthine segment was observed in one nerve (3%); at the geniculate ganglion in seven (18%); at the tympanic segment in 18 (45%) and at the mastoid segment in 28 nerves (70%). Our results indicate that enhancement of the facial nerve in normal subjects is not a rare condition.     

Obstructive nephropathy: evaluation with dynamic Gd-DTPA-enhanced MR imaging

The potential of dynamic gadolinium diethylenetriaminepentaacetic acid (DTPA)-enhanced magnetic resonance (MR) imaging for the examination of obstructive nephropathy was analyzed in 27 subjects (five healthy subjects, seven patients with dilated nonobstructed kidneys, six patients with acute obstruction, and nine patients with chronic obstruction) with use of a 1.5-T magnet. Morphologic findings were compared with quantitative analysis of temporal changes in signal intensity. Dynamic postcontrast images of the normal kidney demonstrated four phases of enhancement; cortical enhancement phase, early tubular phase, ductal phase, and excretory phase. The pattern of enhancement in dilated nonobstructed kidneys was similar to that in normal kidneys. In acutely obstructed kidneys, cortical enhancement was similar to that in normal kidneys (17% increase), but medullary enhancement was higher than normal, resulting in diminished corticomedullary differentiation. The early tubular phase was prolonged (until 2.5 minutes after injection), with delayed appearance of the ductal and excretory phases. In chronically obstructed kidneys, the increase in cortical intensity was less than that in normal kidneys (13% increase). The early tubular phase was prolonged, and the ductal phase was diminished or absent.     

Dyke award. Gd-DTPA-enhanced MR imaging of experimental bacterial meningitis: evaluation and comparison with CT

Gd-DTPA-enhanced MR images of experimental bacterial meningitis were obtained after Staphylococcus aureus was inoculated directly into the cisterna magna of four dogs. Each animal was studied with both unenhanced and enhanced MR and CT with Gd-DTPA and meglumine iothalamate, respectively. The enhancement patterns resulting from these techniques were compared and images were correlated with histopathology. All animals demonstrated abnormal leptomeningeal enhancement on MR with Gd-DTPA, but only one of four dogs exhibited abnormal contrast enhancement on CT. In these animals Gd-DTPA-enhanced MR also identified complications of meningitis, such as ventriculitis and cerebritis, more effectively than CT did. Unenhanced MR was not helpful in identifying meningitis. Histologic evaluation demonstrated that the abnormal areas of contrast enhancement on MR and CT correlated with inflammatory cell infiltration. However, some regions of mild leptomeningitis, ependymitis, and cerebritis identified histologically did not demonstrate abnormal enhancement. Since the animal model used was clinically and pathologically similar to human meningitis, we propose that Gd-DTPA-enhanced MR will subsequently be found more effective than unenhanced MR and IV contrast-enhanced CT for demonstrating meningitis and its complications in humans.     

Myocutaneous flap failure: early detection with Gd-DTPA-enhanced MR imaging

Magnetic resonance (MR) imaging was used to evaluate myocutaneous flap viability in an animal model. Bilateral myocutaneous panniculus carnosus groin flaps were created in 14 piglets. Eight of the piglets underwent early occlusion of the vascular pedicle to one flap that resulted in flap failure in all cases. Six piglets underwent late occlusion of the vascular pedicle to one flap that resulted in flap survival in all cases. Spin-echo T1- and T2-weighted MR images were obtained from all piglets 2 and 24 hours after occlusion. Additional gadolinium diethylene-triaminepentaacetic acid (DTPA)-enhanced serial T1-weighted images were obtained in four piglets who underwent early occlusion and in four piglets who underwent late occlusion of the pedicle. The T2-weighted images showed increased signal intensity in both occluded and control flaps and thus did not help predict flap viability. Gd-DTPA-enhanced images enabled accurate prediction of flap viability. The images of early-occluded (non-viable) flaps demonstrated no contrast material enhancement, while both the late-occluded (viable) flaps and the control flaps were contrast enhanced. The authors conclude that Gd-DTPA-enhanced MR imaging can help predict myocutaneous flap viability in piglets.     

Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging

Dynamic contrast material-enhanced gradient-echo magnetic resonance (MR) imaging was performed on 15 patients with 18 renal masses (seven simple renal cysts, nine renal cell carcinomas, one angiomyolipoma, and one oncocytoma). Fifteen sequential images were obtained while the patients held their breath during a 2.5-3.5-minute interval during and immediately after the intravenous administration of gadolinium diethylenetriaminepentaacetic acid (DTPA); delayed images were also obtained for 15 minutes. Time-intensity curves showed that renal cortical enhancement reached maximal intensity 80 seconds after the injection of Gd-DTPA. Medullary enhancement reached maximal intensity at 120 seconds. None of the simple renal cysts showed enhancement; each cyst displayed a signal intensity less than that of the renal cortex on precontrast images. All renal cell carcinomas were isointense with the renal cortex and demonstrated variable enhancement. Three patterns of enhancement were observed: predominantly peripheral, heterogeneous, and homogeneous. Both the angiomyolipoma and the oncocytoma showed brisk, homogeneous enhancement. This MR imaging technique appears to be useful in the detection and characterization of simple renal cysts and solid neoplasms.     

Chronic inflammatory disease of the middle ear cavities: Gd-DTPA-enhanced MR imaging

Twenty-seven patients with chronic middle ear infection were prospectively studied with pre- and post-contrast magnetic resonance (MR) images to assess the role of MR imaging in the recognition of middle ear tissue abnormalities. The findings were correlated with computed tomographic (CT) scans and surgical and pathologic data. Granulation tissue constantly appeared enhanced on studies done with gadolinium diethylenetriaminepentaacetic acid (DTPA), unlike cholesteatoma, cholesterol granuloma, or brain herniation into the middle ear cavities. Evaluation of extension and thickness of the inflammatory tissue with MR imaging was in accordance with surgical findings. In six cases, isolated granulation tissue misdiagnosed as either a cholesteatoma or herniated brain on CT scans was accurately evaluated on postcontrast MR images. When granulation tissue was associated with other soft-tissue masses, Gd-DTPA-enhanced MR images allowed accurate definition of the site and the extension of each lesion. Furthermore, abnormal meningeal enhancement was precisely depicted by MR images in two cases.     

Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors

The effect of gadolinium diethylenetriaminepentaacetic acid (DTPA) on the sensitivity of cranial magnetic resonance (MR) imaging was measured in a prospective blinded study. Twenty-two consecutive patients with benign extraaxial tumors underwent MR imaging on a 1.5-T system without and with intravenous administration of Gd-DTPA. Readers independently interpreted the unenhanced and enhanced images without clinical information. The interpretations were compared with the anatomically verified diagnoses. Gd-DTPA improved the sensitivity of MR imaging for benign extraaxial tumors, especially in cases of residual or recurrent acoustic neuromas, multiple tumors (e.g., neurofibromatosis), or inconclusive unenhanced MR images. Enhancement with Gd-DTPA impaired the identification of a skull base tumor.     

Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging

Twenty pediatric patients, aged 2-18 years, with known or suspected masses in the brain and/or spinal cord were studied with magnetic resonance imaging at 0.6T with and without use of 0.1 mmol/kg gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA). The multisection, multiecho imaging mode was utilized. Surgically proved mass lesions included astrocytoma (n = 6), medulloblastoma (n = 2), ependymoma (n = 1), craniopharyngioma (n = 1), oligodendroglioma (n = 1), germinoma (n = 1) and fibrosarcoma (n = 1). Presumptive diagnoses included astrocytoma (n = 3), arachnoid cyst (n = 1), tuberous sclerosis (n = 1), cryptic vascular malformation (n = 1), and normal (n = 1). There was dramatic enhancement in 11 of 20 patients, with improved definition of the presence and extent of lesions in six patients. No adverse effects were noted in any of the 20 patients. It is concluded that Gd-DTPA is useful in delineating the presence, extent, and number of certain lesions of the central nervous system in children.